pre-seed
Stage
2
Investors
About
One BioMed develops molecular diagnostic platforms along with automated instruments for nucleic acid extraction and purification, aimed at facilitating rapid biomedical research and point-of-care testing.
Explore One BioMed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.